129 related articles for article (PubMed ID: 26298011)
1. Treg-Mediated Immune Tolerance and the Risk of Solid Cancers: Findings From EPIC-Heidelberg.
Barth SD; Schulze JJ; Kühn T; Raschke E; Hüsing A; Johnson T; Kaaks R; Olek S
J Natl Cancer Inst; 2015 Nov; 107(11):. PubMed ID: 26298011
[TBL] [Abstract][Full Text] [Related]
2. The Ratio of Regulatory (FOXP3+) to Total (CD3+) T Cells Determined by Epigenetic Cell Counting and Cardiovascular Disease Risk: A Prospective Case-cohort Study in Non-diabetics.
Barth SD; Kaaks R; Johnson T; Katzke V; Gellhaus K; Schulze JJ; Olek S; Kühn T
EBioMedicine; 2016 Sep; 11():151-156. PubMed ID: 27499494
[TBL] [Abstract][Full Text] [Related]
3. Tumor-infiltrating lymphocytes, tumor characteristics, and recurrence in patients with early breast cancer.
Kim ST; Jeong H; Woo OH; Seo JH; Kim A; Lee ES; Shin SW; Kim YH; Kim JS; Park KH
Am J Clin Oncol; 2013 Jun; 36(3):224-31. PubMed ID: 22495453
[TBL] [Abstract][Full Text] [Related]
4. Risk factors: Immune tolerance confers cancer risk.
Sidaway P
Nat Rev Clin Oncol; 2015 Oct; 12(10):564. PubMed ID: 26346843
[No Abstract] [Full Text] [Related]
5. The prognostic value of FOXP3+ T regulatory cells in colorectal cancer.
Vlad C; Kubelac P; Fetica B; Vlad D; Irimie A; Achimas-Cadariu P
J BUON; 2015; 20(1):114-9. PubMed ID: 25778305
[TBL] [Abstract][Full Text] [Related]
6. Sex hormone levels and risks of estrogen receptor-negative and estrogen receptor-positive breast cancers.
Farhat GN; Cummings SR; Chlebowski RT; Parimi N; Cauley JA; Rohan TE; Huang AJ; Vitolins M; Hubbell FA; Manson JE; Cochrane BB; Lane DS; Lee JS
J Natl Cancer Inst; 2011 Apr; 103(7):562-70. PubMed ID: 21330633
[TBL] [Abstract][Full Text] [Related]
7. Fusobacterium nucleatum and T Cells in Colorectal Carcinoma.
Mima K; Sukawa Y; Nishihara R; Qian ZR; Yamauchi M; Inamura K; Kim SA; Masuda A; Nowak JA; Nosho K; Kostic AD; Giannakis M; Watanabe H; Bullman S; Milner DA; Harris CC; Giovannucci E; Garraway LA; Freeman GJ; Dranoff G; Chan AT; Garrett WS; Huttenhower C; Fuchs CS; Ogino S
JAMA Oncol; 2015 Aug; 1(5):653-61. PubMed ID: 26181352
[TBL] [Abstract][Full Text] [Related]
8. Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance.
Arpino G; Weiss H; Lee AV; Schiff R; De Placido S; Osborne CK; Elledge RM
J Natl Cancer Inst; 2005 Sep; 97(17):1254-61. PubMed ID: 16145046
[TBL] [Abstract][Full Text] [Related]
9. Serum total thiol levels and the risk of lung, colorectal, breast and prostate cancer: A prospective case-cohort study.
Gào X; Wilsgaard T; Jansen EHJM; Xuan Y; Anusruti A; Brenner H; Schöttker B
Int J Cancer; 2020 Mar; 146(5):1261-1267. PubMed ID: 31125113
[TBL] [Abstract][Full Text] [Related]
10. Circulating liver enzymes and risks of chronic diseases and mortality in the prospective EPIC-Heidelberg case-cohort study.
Katzke V; Johnson T; Sookthai D; Hüsing A; Kühn T; Kaaks R
BMJ Open; 2020 Mar; 10(3):e033532. PubMed ID: 32152162
[TBL] [Abstract][Full Text] [Related]
11. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).
Kaaks R; Berrino F; Key T; Rinaldi S; Dossus L; Biessy C; Secreto G; Amiano P; Bingham S; Boeing H; Bueno de Mesquita HB; Chang-Claude J; Clavel-Chapelon F; Fournier A; van Gils CH; Gonzalez CA; Gurrea AB; Critselis E; Khaw KT; Krogh V; Lahmann PH; Nagel G; Olsen A; Onland-Moret NC; Overvad K; Palli D; Panico S; Peeters P; Quirós JR; Roddam A; Thiebaut A; Tjønneland A; Chirlaque MD; Trichopoulou A; Trichopoulos D; Tumino R; Vineis P; Norat T; Ferrari P; Slimani N; Riboli E
J Natl Cancer Inst; 2005 May; 97(10):755-65. PubMed ID: 15900045
[TBL] [Abstract][Full Text] [Related]
12. Active smoking and breast cancer risk: original cohort data and meta-analysis.
Gaudet MM; Gapstur SM; Sun J; Diver WR; Hannan LM; Thun MJ
J Natl Cancer Inst; 2013 Apr; 105(8):515-25. PubMed ID: 23449445
[TBL] [Abstract][Full Text] [Related]
13. The cellular ratio of immune tolerance (immunoCRIT) is a definite marker for aggressiveness of solid tumors and may explain tumor dissemination patterns.
Türbachova I; Schwachula T; Vasconcelos I; Mustea A; Baldinger T; Jones KA; Bujard H; Olek A; Olek K; Gellhaus K; Braicu I; Könsgen D; Fryer C; Ravot E; Hellwag A; Westerfeld N; Gruss OJ; Meissner M; Hasan MT; Weber M; Hoffmüller U; Zimmermann S; Loddenkemper C; Mahner S; Babel N; Berns E; Adams R; Zeilinger R; Baron U; Vergote I; Maughan T; Marme F; Dickhaus T; Sehouli J; Olek S
Epigenetics; 2013 Nov; 8(11):1226-35. PubMed ID: 24071829
[TBL] [Abstract][Full Text] [Related]
14. Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
Chlebowski RT; Anderson GL; Lane DS; Aragaki AK; Rohan T; Yasmeen S; Sarto G; Rosenberg CA; Hubbell FA;
J Natl Cancer Inst; 2007 Nov; 99(22):1695-705. PubMed ID: 18000216
[TBL] [Abstract][Full Text] [Related]
15. Role of Foxp3-positive tumor-infiltrating lymphocytes in the histologic features and clinical outcomes of hepatocellular carcinoma.
Mathai AM; Kapadia MJ; Alexander J; Kernochan LE; Swanson PE; Yeh MM
Am J Surg Pathol; 2012 Jul; 36(7):980-6. PubMed ID: 22446942
[TBL] [Abstract][Full Text] [Related]
16. Recreational physical activity and risk of postmenopausal breast cancer based on hormone receptor status.
Bardia A; Hartmann LC; Vachon CM; Vierkant RA; Wang AH; Olson JE; Sellers TA; Cerhan JR
Arch Intern Med; 2006 Dec 11-25; 166(22):2478-83. PubMed ID: 17159013
[TBL] [Abstract][Full Text] [Related]
17. Hip circumference is associated with the risk of premenopausal ER-/PR- breast cancer.
Fagherazzi G; Chabbert-Buffet N; Fabre A; Guillas G; Boutron-Ruault MC; Mesrine S; Clavel-Chapelon F
Int J Obes (Lond); 2012 Mar; 36(3):431-9. PubMed ID: 21427693
[TBL] [Abstract][Full Text] [Related]
18. Food sources of fat and sex hormone receptor status of invasive breast tumors in women of the Malmö Diet and Cancer cohort.
Wirfält E; Li C; Manjer J; Ericson U; Sonestedt E; Borgquist S; Landberg G; Olsson H; Gullberg B
Nutr Cancer; 2011; 63(5):722-33. PubMed ID: 21767080
[TBL] [Abstract][Full Text] [Related]
19. Body weight correlates with mortality in early-stage breast cancer.
Enger SM; Greif JM; Polikoff J; Press M
Arch Surg; 2004 Sep; 139(9):954-58; discussion 958-60. PubMed ID: 15381612
[TBL] [Abstract][Full Text] [Related]
20. Acute rejection, T-cell-depleting antibodies, and cancer after transplantation.
Lim WH; Turner RM; Chapman JR; Ma MK; Webster AC; Craig JC; Wong G
Transplantation; 2014 Apr; 97(8):817-25. PubMed ID: 24521777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
